Search research articles
Contact Us
Filters
Showing results (1711-1720 of 1,779) with videos related to
Page
of 178
Sort By:
Mabs
|
January 30, 2025
Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study
Jennifer Moore, Alicia Aylott, Wen-Hung Chen, et al.
Mabs
|
March 17, 2025
A novel <i>in vitro</i> serum stability assay for antibody therapeutics incorporating internal standards
Yihan Li, Rosendo Villafuerte-Vega, Vikram M Shenoy, et al.
Mabs
|
January 8, 2025
Prediction of protein biophysical traits from limited data: a case study on nanobody thermostability through NanoMelt
Aubin Ramon, Mingyang Ni, Olga Predeina, et al.
Mabs
|
January 6, 2025
A bispecific antibody-drug conjugate targeting pCAD and CDH17 has antitumor activity and improved tumor-specificity
Alyssa Synan, Nila C Wu, Roberto Velazquez, et al.
Mabs
|
March 5, 2025
Folate receptor alpha for cancer therapy: an antibody and antibody-drug conjugate target coming of age
Yi Liu, Xinyi Chen, Theodore Evan, et al.
Mabs
|
February 28, 2025
Prediction of long-term stability of high-concentration formulations to support rapid development of antibodies against SARS-CoV-2
Lin Luo, Michael Meleties, Julie Beaudet, et al.
Mabs
|
August 27, 2024
Developability considerations for bispecific and multispecific antibodies
Alaa Amash, Gesa Volkers, Patrick Farber, et al.
Mabs
|
August 28, 2024
Expanding the structural resolution of glycosylation microheterogeneity in therapeutic proteins by salt-free hydrophilic interaction liquid chromatography tandem mass spectrometry
Yutian Gan, Steffen Lippold, John Stobaugh, et al.
Mabs
|
November 25, 2024
Agonistic anti-NKG2D antibody structure reveals unique stoichiometry and epitope compared to natural ligands
Daniel Fallon, Ching-Shin Huang, Jingya Ma, et al.
Mabs
|
November 21, 2024
Multivariate quantitative analysis of glycan impact on IgG1 effector functions
Tamara Cvijić, Matej Horvat, Jakob Plahutnik, et al.
Page
of 178
Search research articles
Search
Showing results (1711-1720 of 1,779) with videos related to
Sort By:
Page
of 178
Mabs
|
January 30, 2025
Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study
Jennifer Moore, Alicia Aylott, Wen-Hung Chen, et al.
Mabs
|
March 17, 2025
A novel <i>in vitro</i> serum stability assay for antibody therapeutics incorporating internal standards
Yihan Li, Rosendo Villafuerte-Vega, Vikram M Shenoy, et al.
Mabs
|
January 8, 2025
Prediction of protein biophysical traits from limited data: a case study on nanobody thermostability through NanoMelt
Aubin Ramon, Mingyang Ni, Olga Predeina, et al.
Mabs
|
January 6, 2025
A bispecific antibody-drug conjugate targeting pCAD and CDH17 has antitumor activity and improved tumor-specificity
Alyssa Synan, Nila C Wu, Roberto Velazquez, et al.
Mabs
|
March 5, 2025
Folate receptor alpha for cancer therapy: an antibody and antibody-drug conjugate target coming of age
Yi Liu, Xinyi Chen, Theodore Evan, et al.
Mabs
|
February 28, 2025
Prediction of long-term stability of high-concentration formulations to support rapid development of antibodies against SARS-CoV-2
Lin Luo, Michael Meleties, Julie Beaudet, et al.
Mabs
|
August 27, 2024
Developability considerations for bispecific and multispecific antibodies
Alaa Amash, Gesa Volkers, Patrick Farber, et al.
Mabs
|
August 28, 2024
Expanding the structural resolution of glycosylation microheterogeneity in therapeutic proteins by salt-free hydrophilic interaction liquid chromatography tandem mass spectrometry
Yutian Gan, Steffen Lippold, John Stobaugh, et al.
Mabs
|
November 25, 2024
Agonistic anti-NKG2D antibody structure reveals unique stoichiometry and epitope compared to natural ligands
Daniel Fallon, Ching-Shin Huang, Jingya Ma, et al.
Mabs
|
November 21, 2024
Multivariate quantitative analysis of glycan impact on IgG1 effector functions
Tamara Cvijić, Matej Horvat, Jakob Plahutnik, et al.
Page
of 178